These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11193669)

  • 41. Molecular basis for vaccine development against anaplasmosis and babesiosis.
    Palmer GH; McElwain TF
    Vet Parasitol; 1995 Mar; 57(1-3):233-53. PubMed ID: 7597787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of cattle responses to mono-specific or combined inoculations with Babesia bigemina and Babesia bovis vaccine strains.
    Viseras J; Lugaresi CI; Volpogni MM; Guglielmone AA
    Parasite; 1999 Mar; 6(1):67-9. PubMed ID: 10229940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on failure of T strain live Babesia bovis vaccine.
    Bock RE; de Vos AJ; Lew A; Kingston TG; Fraser IR
    Aust Vet J; 1995 Aug; 72(8):296-300. PubMed ID: 8579560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigations of breakdowns in protection provided by living Babesia bovis vaccine.
    Bock RE; de Vos AJ; Kingston TG; Shiels IA; Dalgliesh RJ
    Vet Parasitol; 1992 Jun; 43(1-2):45-56. PubMed ID: 1496802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transgenic Babesia bovis lacking 6-Cys sexual-stage genes as the foundation for non-transmissible live vaccines against bovine babesiosis.
    Alzan HF; Cooke BM; Suarez CE
    Ticks Tick Borne Dis; 2019 Apr; 10(3):722-728. PubMed ID: 30711475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccination with an
    Bastos RG; Capelli-Peixoto J; Laughery JM; Suarez CE; Ueti MW
    Front Immunol; 2023; 14():1219913. PubMed ID: 37583702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Babesia divergens vaccine.
    Gorenflot A; Precigout E; Valentin A; Bissuel G; Carcy B; Brasseur P; Moreau Y; Schrevel J
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():279-81. PubMed ID: 1343703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An immunisation trial with in vitro produced Babesia bigemina exoantigens.
    Beniwal RP; Nichani AK; Rakha NK; Sharma RD; Sarup S
    Trop Anim Health Prod; 1997 Nov; 29(4 Suppl):124S-126S. PubMed ID: 9512758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Culture-derived parasites in vaccination of cattle against tick-borne diseases.
    Shkap V; Pipano E
    Ann N Y Acad Sci; 2000; 916():154-71. PubMed ID: 11193616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The development of a recombinant Babesia vaccine.
    Wright IG; Casu R; Commins MA; Dalrymple BP; Gale KR; Goodger BV; Riddles PW; Waltisbuhl DJ; Abetz I; Berrie DA
    Vet Parasitol; 1992 Sep; 44(1-2):3-13. PubMed ID: 1441189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate.
    Hope M; Riding G; Menzies M; Colditz I; Reverter A; Willadsen P
    Parasite Immunol; 2005 Dec; 27(12):439-45. PubMed ID: 16255742
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Live vaccines against hemoparasitic diseases in livestock.
    Pipano E
    Vet Parasitol; 1995 Mar; 57(1-3):213-31. PubMed ID: 7597786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of novel immune correlates of protection against acute bovine babesiosis by superinfecting cattle with
    Bastos RG; Laughery JM; Ozubek S; Alzan HF; Taus NS; Ueti MW; Suarez CE
    Front Immunol; 2022; 13():1045608. PubMed ID: 36466866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular and antigenic characterisation of ribosomal phosphoprotein P0 from Babesia bovis.
    Ramos CA; Araújo FR; Souza II; Oliveira RH; Elisei C; Soares CO; Sacco AM; Rosinha GM; Alves LC
    Mem Inst Oswaldo Cruz; 2009 Nov; 104(7):998-1002. PubMed ID: 20027467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful vaccination against Boophilus microplus and Babesia bovis using recombinant antigens.
    Willadsen P; Kemp DH; Cobon GS; Wright IG
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():289-94. PubMed ID: 1343705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bovine babesiosis live vaccine production: use of gamma irradiation on the substrate.
    Rojas C; Figueroa JV; Alvarado A; Mejia P; Mosqueda JJ; Falcon A; Vega CA; Alvarez A
    Ann N Y Acad Sci; 2006 Oct; 1081():405-16. PubMed ID: 17135544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a highly infective Babesia bigemina vaccine of reduced virulence.
    Dalgliesh RJ; Callow LL; Mellors LT; McGregor W
    Aust Vet J; 1981 Jan; 57(1):8-11. PubMed ID: 7236153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PCR-based detection of Babesia bovis and Babesia bigemina in their natural host Boophilus microplus and cattle.
    Oliveira-Sequeira TC; Oliveira MC; Araujo JP; Amarante AF
    Int J Parasitol; 2005 Jan; 35(1):105-11. PubMed ID: 15619521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of different direct diagnostic methods to identify Babesia bovis and Babesia bigemina in animals vaccinated with live attenuated parasites.
    Costa-Júnior LM; Rabelo EM; Martins Filho OA; Ribeiro MF
    Vet Parasitol; 2006 Jun; 139(1-3):231-6. PubMed ID: 16580136
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Post-thawing viability of vaccines for bovine babesiosis and anaplasmosis cryopreserved with glycerol.
    Mangold AJ; Aguirre DH; Guglielmone AA
    Vet Parasitol; 1990 Nov; 37(3-4):301-6. PubMed ID: 2267730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.